Cybiocare is proud to introduce
the world’s first Optical Hypoglycemia Detector (OHD), now in full prototype and testing stage. The Cybiocare OHD is designed as a totally non-invasive way to help prevent hypoglycemia among the millions of people with diabetes today.

Photonic medical devices

Cybiocare (sigh-bee-oh-care) was founded in 2001 with the mission to improve quality of life for millions of people around the world by developing, manufacturing and marketing non-invasive photonic medical devices with an initial focus on the burgeoning market for diabetes control.

The company is currently developing photonics-based products to accurately measure a full range of clinical states including heart beat, blood perfusion, oximetry, hydration and relative glucose trend, as well as tissue temperature and humidity. Cybiocare photonic medical devices are designed for portable monitoring and point-of-care testing at home or in research, clinical, hospital and even sports settings.

Photonics technology is what makes it non-invasive
Photonics technology transforms and guides light to measure, compute, detect and communicate information with greater efficiency, speed and precision than ever before. Cybiocare is putting the latest advances in photonics technology to work creating non-invasive medical devices for a wide variety of disease and pathogenic applications.

“Applications of new optical technologies to biology and medicine might be described as in an adolescent stage, where their power and potential can be recognized but are still developing rapidly, and much is yet to come.”

• Charles H. Townes, Nobel Prize Winner in Physics and co-inventor of the laser in a review of the 2003 edition of the Biomedical Photonics Handbook

Partners

Cybiocare president Michel Bédard and vice-president of research and development Dany Nolet have extensive hands-on business experience in optics, photonics and high technology product development. They lead a multidisciplinary team that is hard at work ensuring that Cybiocare photonics-based medical devices meet or exceed the highest opto-electronic, statistical analysis, clinical factor and medical standards.

The company is also exploring a number of strategic alliances and partnerships with leading players in global healthcare to commercialize its product line.